Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

IARC monographs on the evaluation of carcinogenic risks to humans, 301, 49-54, 2007

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

PMID18756632

Read at source

Abstract not indexed. Read at source

oral contraceptive cancer attributable fraction breast cervical endometrial, population attributable fraction hormonal factors cancer Italy, combined oral contraceptive cancer prevention endometrial ovarian, breastfeeding parity breast cancer prevention population level, menopausal hormone therapy breast cancer attributable risk, reproductive factors cancer burden Italian women, oral contraceptive cervical cancer risk attributable fraction, exogenous hormones colorectal cancer prevention women, Turati La Vecchia cancer attributable reproductive factors Italy, hormonal contraception cancer cases prevented mortality estimate

PMID 18756632 18756632

Cite this article

International Agency for Research on Cancer (2007). Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC monographs on the evaluation of carcinogenic risks to humans, 91, 1-528.